Luis
Pérez de Llano
![Foto de Luis](/img/nophoto.png)
![Foto de Hospital de la Santa Creu i Sant Pau](/img/noimage_org.png)
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublications in collaboration with researchers from Hospital de la Santa Creu i Sant Pau (13)
2023
-
Quality indicators in the rational management of severe asthma: A Spanish multidisciplinary consensus
Journal of Healthcare Quality Research, Vol. 38, Núm. 5, pp. 277-283
-
Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response
Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13
-
Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population
Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 842-845
-
Validation of the Asthma Impairment and Risk Questionnaire in Spain: A Useful Tool for Assessing Asthma Control in Adolescents and Adults
Journal of Investigational Allergology and Clinical Immunology
2022
-
Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases
Archivos de Bronconeumologia, Vol. 58, pp. 39-50
2020
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068
2018
-
Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: A network approach
International Journal of COPD, Vol. 13, pp. 591-601
2017
-
Asthma-COPD overlap is not a homogeneous disorder: Further supporting data
Respiratory Research
2016
-
GEMA 4.0 Spanish guidelines of the management of Asthma
Journal of Investigational Allergology and Clinical Immunology
-
Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients
Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152